All-cause mortality during the influenza season 20192020: comparison with previous influenza seasons in the territory of the local health authority “Central Tuscany”, Italy
Keywords:
Influenza season, excess mortality, COVID-19Abstract
Introduction. Because of the 24 months latency in the release of official data on causes of death, and in consideration of the limited testing capacity during the first pandemic wave, to estimate the COVID-19related mortality in 2020, the evaluation of all-cause mortality excess is often used instead. Our study aimed at assessing whether in Central Tuscany, Italy, an excess all-cause mortality occurred in the 2019-2020 influenza season, which partly overlapped with the months of the first pandemic wave in which the impact of COVID-19 was the highest.
Materials and Methods. Age- and sex-adjusted mortality rates for 2019-2020 influenza season were compared with those of influenza seasons 2009-2010 to 2016-2017.
Results. No all-cause mortality excess was observed in the 2019-2020 influenza season, which, on the contrary, was characterized by the lowest all-cause mortality rate.
Conclusion. Our finding can be explained by the imposition, in early March 2020, of a national lockdown, which came into effect in an early epidemic phase in Tuscany, and thus limited the transmission of SARSCoV-2 infection, as well as influenza, in the territory. In March and April, by causing the death of vulnerable elderly patients who had been spared by the mild seasonal flu in the prior months, COVID-19 acted with a harvesting effect.
References
1. Rosano A, Bella A, Gesualdo F, et al. Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14–2016/17 seasons). Int J Infect Dis 2019; 88: 127-34. doi:10.1016/j. ijid.2019.08.003.
2. Mølbak K, Espenhain L, Nielsen J, et al. Excess mortality among the elderly in European countries, December 2014 to February 2015. Euro Surveill 2015; 20(11). doi:10.2807/15607917.ES2015.20.11.21065.
3. Stewart S, Keates AK, Redfern A, McMurray JJ V. Seasonal variations in cardiovascular disease. Nat Rev Cardiology 2017; 14(11): 654-64. doi:10.1038/nrcardio.2017.76.
4. Di Q, Dai L, Wang Y, Zanobetti A, et al. Association of short-term exposure to air pollution with mortality in older adults. JAMA 2017; 318(24): 2446-56. doi: 10.1001/jama.2017.17923.
5. Murtas R, Russo AG. Effects of pollution, low temperature and influenza syndrome on the ex-
cess mortality risk in winter 2016-2017. BMC Public Health 2019; 19(1): 1445. doi: 10.1186/ s12889-019-7788-8.
6. Alicandro G, Remuzzi G, La Vecchia C. Italy’s first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020. Lancet 2020; 396(10253): e27-8. doi:10.1016/S0140-6736(20)31865-1.
7. Odone A, Delmonte D, Gaetti G, Signorelli C. Doubled mortality rate during the COVID-19 pandemic in Italy: quantifying what is not captured by surveillance. Public Health 2021; 190: 10815. doi:10.1016/j.puhe.2020.11.016. Epub 2020 Nov 3.
8. Bertuzzo E, Mari L, Pasetto D, et al. The geography of COVID-19 spread in Italy and implications for the relaxation of confinement measures. Nat Commun 2020; 11(1): 4264. doi: 10.1038/s41467-020-18050-2.
9. Italian National Institute of Statistics. Death and causes of death: what does ISTAT produces. Total provincial deaths table for the years 2015-2019, for the year 2020 and for January 2021 Available on: https://www.istat.it/it/archivio/240401 [Last accessed: 15th April 2021].
10. Sara D, Forni S, Gemmi F, et al. Epidemiologic Surveillance of Infectious Diseases in Tuscany [La sorveglianza epidemiologica delle malattie infettive in Toscana]. Florence, Italy, 2021. Available on: https://www.ars.toscana. it/2-articoli/4504-sorveglianza-epidemiologicamalattie-infettive-toscana-rapporto-2019.html [Last accessed: 9th February 2021].
11. Apolone G, Montomoli E, Boeri M, et al. Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori 2020 Nov 11: 300891620974755. doi:10.1177/0300891620974755. Epub ahead of print.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.